EN
抗体药类似物
Research Grade Libivirumab
All
TD-VK539036_1.jpg
TD-VK539036_2.jpg
TD-VK539036_3.jpg
  • CatalogTD-VK539036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • Synonyms17.1.41,HepeX-B(combinationofexbivirumabandlibivirumab),CAS:569658-79-3
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Libivirumab


Catalog No. TD-VK539036
Description Libivirumab is a human monoclonal antibody directed against the hepatitis B virus. Libivirumab had an IC50 of 35 and 128 ng/ml in the neutralization assays based on ELISA and immunofluorescence assays.
Species reactivity Hepatitis B virus genotype A (HBV-A)
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P03142
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names 17.1.41,HepeX-B(combinationofexbivirumabandlibivirumab),CAS:569658-79-3
Background Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK539036_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Libivirumab.
TD-VK539036_2.jpg
Bioactivity
 
Detects S/L-HBsAg/L glycoprotein in indirect ELISAs.
TD-VK539036_3.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Libivirumab.